CTU1
gene geneOn this page
Also known as MGC17332NCS6
Summary
CTU1 (cytosolic thiouridylase subunit 1, HGNC:29590) is a protein-coding gene on chromosome 19q13.41, encoding Cytoplasmic tRNA 2-thiolation protein 1 (Q7Z7A3). Plays a central role in 2-thiolation of mcm(5)S(2)U at tRNA wobble positions of tRNA(Lys), tRNA(Glu) and tRNA(Gln). It is a selective cancer dependency (DepMap: 28.1% of cell lines).
Predicted to enable tRNA binding activity. Predicted to be involved in tRNA wobble position uridine thiolation. Located in cytosol.
Source: NCBI Gene 90353 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 74 total
- Cancer dependency (DepMap): dependent in 28.1% of screened cell lines
- MANE Select transcript:
NM_145232
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29590 |
| Approved symbol | CTU1 |
| Name | cytosolic thiouridylase subunit 1 |
| Location | 19q13.41 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC17332, NCS6 |
| Ensembl gene | ENSG00000142544 |
| Ensembl biotype | protein_coding |
| OMIM | 612694 |
| Entrez | 90353 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000421832, ENST00000936078, ENST00000951779, ENST00000951780
RefSeq mRNA: 1 — MANE Select: NM_145232
NM_145232
CCDS: CCDS12824
Canonical transcript exons
ENST00000421832 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000954833 | 51104062 | 51104590 |
| ENSE00001604869 | 51097606 | 51099139 |
| ENSE00001768341 | 51108347 | 51108409 |
Expression profiles
Bgee: expression breadth ubiquitous, 129 present calls, max score 91.70.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.5331 / max 59.7376, expressed in 1759 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182375 | 7.5331 | 1759 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| thymus | UBERON:0002370 | 91.70 | silver quality |
| cerebellar vermis | UBERON:0004720 | 88.52 | gold quality |
| quadriceps femoris | UBERON:0001377 | 88.32 | gold quality |
| granulocyte | CL:0000094 | 77.51 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 77.27 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 76.08 | gold quality |
| cortical plate | UBERON:0005343 | 74.55 | gold quality |
| leukocyte | CL:0000738 | 74.32 | gold quality |
| monocyte | CL:0000576 | 74.14 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.82 | gold quality |
| left ovary | UBERON:0002119 | 72.95 | gold quality |
| blood | UBERON:0000178 | 72.16 | gold quality |
| right ovary | UBERON:0002118 | 71.84 | gold quality |
| ovary | UBERON:0000992 | 71.76 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 71.39 | gold quality |
| ventricular zone | UBERON:0003053 | 71.28 | gold quality |
| ganglionic eminence | UBERON:0004023 | 71.11 | gold quality |
| esophagus mucosa | UBERON:0002469 | 70.67 | gold quality |
| myometrium | UBERON:0001296 | 70.49 | gold quality |
| body of uterus | UBERON:0009853 | 70.03 | gold quality |
| esophagus | UBERON:0001043 | 69.87 | gold quality |
| lower esophagus | UBERON:0013473 | 69.78 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 69.78 | gold quality |
| right lobe of liver | UBERON:0001114 | 69.75 | gold quality |
| gastrocnemius | UBERON:0001388 | 69.58 | gold quality |
| primary visual cortex | UBERON:0002436 | 69.58 | gold quality |
| left adrenal gland | UBERON:0001234 | 69.53 | gold quality |
| cortex of kidney | UBERON:0001225 | 69.43 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 69.30 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 69.28 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.63 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting CTU1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-548AG | 99.77 | 69.25 | 1492 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-6887-3P | 99.66 | 67.83 | 1778 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-6733-3P | 99.54 | 67.80 | 1281 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
| HSA-MIR-4667-3P | 99.26 | 65.45 | 1608 |
| HSA-MIR-6749-3P | 99.00 | 65.73 | 1443 |
| HSA-MIR-6887-5P | 98.56 | 68.49 | 1295 |
| HSA-MIR-6795-5P | 98.52 | 68.51 | 1277 |
| HSA-MIR-6880-5P | 98.08 | 65.59 | 1282 |
| HSA-MIR-203B-5P | 97.24 | 68.54 | 543 |
| HSA-MIR-6718-5P | 97.24 | 68.15 | 553 |
| HSA-MIR-4286 | 97.20 | 64.37 | 1587 |
| HSA-MIR-125A-3P | 97.04 | 66.92 | 902 |
| HSA-MIR-6823-5P | 96.26 | 65.69 | 919 |
| HSA-MIR-3943 | 95.87 | 64.57 | 523 |
| HSA-MIR-139-3P | 95.24 | 63.10 | 316 |
| HSA-MIR-769-5P | 94.45 | 64.56 | 603 |
| HSA-MIR-1296-5P | 93.94 | 67.71 | 305 |
| HSA-MIR-6790-3P | 88.15 | 62.55 | 113 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 28.1% of screened cell lines.
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ctu1 | ENSDARG00000020986 |
| mus_musculus | Ctu1 | ENSMUSG00000038888 |
| rattus_norvegicus | Ctu1 | ENSRNOG00000018334 |
| drosophila_melanogaster | Ctu1 | FBGN0033375 |
| caenorhabditis_elegans | WBGENE00017928 |
Protein
Protein identifiers
Cytoplasmic tRNA 2-thiolation protein 1 — Q7Z7A3 (reviewed: Q7Z7A3)
Alternative names: ATP-binding domain-containing protein 3, Cancer-associated gene protein, Cytoplasmic tRNA adenylyltransferase 1
All UniProt accessions (1): Q7Z7A3
UniProt curated annotations — full annotation on UniProt →
Function. Plays a central role in 2-thiolation of mcm(5)S(2)U at tRNA wobble positions of tRNA(Lys), tRNA(Glu) and tRNA(Gln). Directly binds tRNAs and probably acts by catalyzing adenylation of tRNAs, an intermediate required for 2-thiolation. It is unclear whether it acts as a sulfurtransferase that transfers sulfur from thiocarboxylated URM1 onto the uridine of tRNAs at wobble position.
Subunit / interactions. Component of a complex at least composed of URM1, CTU2/NCS2 and CTU1/ATPBD3. May form a heterodimer with CTU2/NCS2.
Subcellular location. Cytoplasm.
Pathway. tRNA modification; 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis.
Similarity. Belongs to the TtcA family. CTU1/NCS6/ATPBD3 subfamily.
RefSeq proteins (1): NP_660275* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000541 | Ncs6/Tuc1/Ctu1 | Family |
| IPR011063 | TilS/TtcA_N | Domain |
| IPR014729 | Rossmann-like_a/b/a_fold | Homologous_superfamily |
| IPR032442 | CTU1_C | Domain |
| IPR035107 | tRNA_thiolation_TtcA_Ctu1 | Family |
| IPR056369 | CTU1-like_ATP-bd | Domain |
Pfam: PF01171, PF16503
UniProt features (5 total): chain 1, region of interest 1, modified residue 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z7A3-F1 | 84.51 | 0.61 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 200
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6782315 | tRNA modification in the nucleus and cytosol |
MSigDB gene sets: 99 (showing top):
GOBP_TRNA_METABOLIC_PROCESS, GOBP_RNA_MODIFICATION, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_TRNA_PROCESSING, REACTOME_METABOLISM_OF_RNA, GOBP_TRNA_MODIFICATION, GOCC_TRANSFERASE_COMPLEX, ER_Q6_02, GOMF_TRNA_BINDING, GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, GOBP_TRNA_WOBBLE_BASE_MODIFICATION, BRUINS_UVC_RESPONSE_LATE, GOBP_TRNA_THIO_MODIFICATION
GO Biological Process (5): tRNA wobble uridine modification (GO:0002098), tRNA wobble position uridine thiolation (GO:0002143), protein urmylation (GO:0032447), tRNA thio-modification (GO:0034227), tRNA processing (GO:0008033)
GO Molecular Function (5): tRNA binding (GO:0000049), nucleotidyltransferase activity (GO:0016779), RNA binding (GO:0003723), protein binding (GO:0005515), transferase activity (GO:0016740)
GO Cellular Component (3): cytosolic tRNA wobble base thiouridylase complex (GO:0002144), cytosol (GO:0005829), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| tRNA processing | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| tRNA wobble base modification | 1 |
| tRNA wobble uridine modification | 1 |
| tRNA thio-modification | 1 |
| protein modification by small protein conjugation | 1 |
| tRNA modification | 1 |
| RNA processing | 1 |
| tRNA metabolic process | 1 |
| RNA binding | 1 |
| transferase activity, transferring phosphorus-containing groups | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| catalytic activity | 1 |
| intracellular protein-containing complex | 1 |
| sulfurtransferase complex | 1 |
| cytoplasm | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
2662 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CTU1 | URM1 | Q9BTM9 | 996 |
| CTU1 | CTU2 | Q2VPK5 | 991 |
| CTU1 | MOCS3 | O95396 | 917 |
| CTU1 | ELP3 | Q9H9T3 | 879 |
| CTU1 | NFS1 | Q9Y697 | 833 |
| CTU1 | MPST | P25325 | 821 |
| CTU1 | MCM5 | P33992 | 719 |
| CTU1 | TRMT112 | Q9UI30 | 718 |
| CTU1 | ELP4 | Q96EB1 | 716 |
| CTU1 | ALKBH8 | Q96BT7 | 703 |
| CTU1 | KTI12 | Q96EK9 | 682 |
| CTU1 | ELP5 | Q8TE02 | 667 |
| CTU1 | TRMU | O75648 | 647 |
| CTU1 | TST | Q16762 | 627 |
| CTU1 | TRMT9B | Q9P272 | 607 |
IntAct
90 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ACBD6 | NMT2 | psi-mi:“MI:0914”(association) | 0.870 |
| URM1 | CTU1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| URM1 | CTU1 | psi-mi:“MI:0407”(direct interaction) | 0.720 |
| CETN1 | SFI1 | psi-mi:“MI:0914”(association) | 0.640 |
| ZNF414 | AHCYL1 | psi-mi:“MI:0914”(association) | 0.640 |
| VWCE | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| SCRN1 | CCDC85C | psi-mi:“MI:0914”(association) | 0.530 |
| VASP | GTPBP1 | psi-mi:“MI:0914”(association) | 0.530 |
| PLA2G10 | CHEK1 | psi-mi:“MI:0914”(association) | 0.530 |
| FHL5 | ZMYM6 | psi-mi:“MI:0914”(association) | 0.530 |
| FBXO2 | TMEM131L | psi-mi:“MI:0914”(association) | 0.530 |
| SLC31A1 | C2orf72 | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEA1 | MAGEB3 | psi-mi:“MI:0914”(association) | 0.530 |
| ECHDC2 | NDUFS6 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNRD2 | MYO9A | psi-mi:“MI:0914”(association) | 0.530 |
| PBXIP1 | KCNN4 | psi-mi:“MI:0914”(association) | 0.530 |
| CHCHD4 | ENSA | psi-mi:“MI:0914”(association) | 0.530 |
| DCAF4 | CLUH | psi-mi:“MI:0914”(association) | 0.530 |
| IMPDH1 | BCAT2 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (95): CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS), CTU1 (Affinity Capture-MS)
ESM2 similar proteins: A1AT10, A1TLF2, A5D3W7, A5GBB7, A5USV2, A7H7H6, A7HAB8, A7HC45, A7HD67, A7HDB0, A7HDI5, A7HID3, A7HIY6, A9EPV3, A9ER52, A9FD89, B1I1S7, B4RGP0, B4UCW3, B4UG90, B4UGJ6, B4UGX0, B4UHQ4, B4UKF8, B8J9F5, B8J9N6, B8JDE1, B8JDI0, B8JDK2, B8JE66, C4XS52, O86751, Q1AVW2, Q1CW50, Q1D568, Q1D7T4, Q1ISF4, Q2IG43, Q2IHR2, Q2IIL0
Diamond homologs: A2Q879, A3GGB3, A3PNA9, A4WWJ3, A5DPQ4, A5E3Q3, A6ZTX8, A7TER7, A8JF71, A8M8I3, A8PVM6, A8WR63, B0DK66, B1WBV0, B3LHQ7, B3MI77, B3N7L9, B4GHY8, B4HSL7, B4J5B3, B4KLL0, B4LM02, B4NN33, B4P3W7, B5RV24, B9KNZ4, D4GSH6, O58038, O64862, O76365, O94282, P0CS70, P0CS71, P53088, Q01QT2, Q05AW7, Q0VC66, Q16A99, Q16QI1, Q1GJX4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
74 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 67 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
306 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:51099137:GACC:G | acceptor_loss | 1.0000 |
| 19:51099139:CCT:C | acceptor_loss | 1.0000 |
| 19:51099140:C:CC | acceptor_gain | 1.0000 |
| 19:51099141:T:A | acceptor_loss | 1.0000 |
| 19:51099143:G:GC | acceptor_gain | 1.0000 |
| 19:51099135:GTGAC:G | acceptor_gain | 0.9900 |
| 19:51099136:TGAC:T | acceptor_gain | 0.9900 |
| 19:51099137:GAC:G | acceptor_gain | 0.9900 |
| 19:51099138:AC:A | acceptor_gain | 0.9900 |
| 19:51099139:CC:C | acceptor_gain | 0.9900 |
| 19:51104056:GCTCA:G | donor_loss | 0.9900 |
| 19:51104057:CTCAC:C | donor_loss | 0.9900 |
| 19:51104058:TCA:T | donor_loss | 0.9900 |
| 19:51104059:CA:C | donor_loss | 0.9900 |
| 19:51104061:CC:C | donor_loss | 0.9900 |
| 19:51099143:G:C | acceptor_gain | 0.9800 |
| 19:51108342:CTCA:C | donor_loss | 0.9800 |
| 19:51108343:TCA:T | donor_loss | 0.9800 |
| 19:51108344:CA:C | donor_loss | 0.9800 |
| 19:51108345:A:AC | donor_gain | 0.9800 |
| 19:51108345:AC:A | donor_gain | 0.9800 |
| 19:51108346:C:CC | donor_gain | 0.9800 |
| 19:51108346:CC:C | donor_gain | 0.9800 |
| 19:51104100:T:TA | donor_gain | 0.9700 |
| 19:51104589:TCC:T | acceptor_loss | 0.9700 |
| 19:51104591:C:CA | acceptor_loss | 0.9700 |
| 19:51104591:C:CC | acceptor_gain | 0.9700 |
| 19:51104592:T:G | acceptor_loss | 0.9700 |
| 19:51108339:ATACT:A | donor_loss | 0.9700 |
| 19:51108345:ACC:A | donor_gain | 0.9700 |
AlphaMissense
2166 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:51099123:G:C | D175E | 0.997 |
| 19:51099123:G:T | D175E | 0.997 |
| 19:51099124:T:A | D175V | 0.997 |
| 19:51099124:T:G | D175A | 0.997 |
| 19:51104130:C:T | C147Y | 0.997 |
| 19:51104384:C:A | K62N | 0.997 |
| 19:51104384:C:G | K62N | 0.997 |
| 19:51104127:C:T | G148E | 0.996 |
| 19:51099099:G:C | N183K | 0.995 |
| 19:51099099:G:T | N183K | 0.995 |
| 19:51099124:T:C | D175G | 0.995 |
| 19:51099125:C:G | D175H | 0.995 |
| 19:51099137:G:C | H171D | 0.995 |
| 19:51104310:A:T | V87D | 0.995 |
| 19:51104381:G:C | D63E | 0.995 |
| 19:51104381:G:T | D63E | 0.995 |
| 19:51098753:A:G | C299R | 0.994 |
| 19:51099132:G:C | N172K | 0.994 |
| 19:51099132:G:T | N172K | 0.994 |
| 19:51099139:C:T | G170D | 0.994 |
| 19:51104116:G:T | R152S | 0.994 |
| 19:51104382:T:A | D63V | 0.994 |
| 19:51104382:T:G | D63A | 0.994 |
| 19:51098752:C:G | C299S | 0.993 |
| 19:51098753:A:T | C299S | 0.993 |
| 19:51104379:G:A | S64F | 0.993 |
| 19:51104383:C:G | D63H | 0.993 |
| 19:51104391:C:T | G60D | 0.993 |
| 19:51099114:C:A | E178D | 0.992 |
| 19:51099114:C:G | E178D | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000183396 (19:51101128 C>T), RS1000235230 (19:51105106 G>A), RS1000235681 (19:51100885 C>T), RS1000473648 (19:51107328 G>A), RS1000677953 (19:51100177 G>A), RS1000702516 (19:51100792 A>G), RS1001358323 (19:51106659 C>T), RS1001809126 (19:51101518 A>C,G), RS1001829898 (19:51107608 G>A), RS1001984012 (19:51101658 T>A), RS1002078245 (19:51102023 A>C), RS1002147096 (19:51101186 T>G), RS1002902899 (19:51109401 G>A,C), RS1003812223 (19:51104813 T>C), RS1003990850 (19:51104439 G>A,C)
Disease associations
OMIM: gene MIM:612694 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Glucose | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.